Raushan T Kurmasheva

Assistant Professor, Greehey Children's Cancer Research Institute

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Raushan T Kurmasheva is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

6 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

1689 Citations
23 h-Index
68 Article
6 Review article
2 Short survey
1 Chapter

A very long-acting PARP inhibitor suppresses cancer cell growth in DNA repair-deficient tumor models
Fontaine, S. D., Ashley, G. W., Houghton, P. J., Kurmasheva, R. T., Diolaiti, M., Ashworth, A., Peer, C. J., Nguyen, R., Figg, W. D., Beckford-Vera, D. R. & Santi, D. V., Feb 15 2021, In: Cancer Research. 81, 4, p. 1076-1086 11 p.
Research output: Contribution to journal › Article › peer-review
In vivo evaluation of the EZH2 inhibitor (EPZ011989) alone or in combination with standard of care cytotoxic agents against pediatric malignant rhabdoid tumor preclinical models—A report from the Pediatric Preclinical Testing Consortium
Kurmasheva, R. T., Erickson, S. W., Earley, E., Smith, M. A. & Houghton, P. J., Feb 2021, In: Pediatric Blood and Cancer. 68, 2, e28772.
Research output: Contribution to journal › Article › peer-review
1 Scopus citations
PCAT: An integrated portal for genomic and preclinical testing data of pediatric cancer patient-derived xenograft models
Yang, J., Li, Q., Noureen, N., Fang, Y., Kurmasheva, R., Houghton, P. J., Wang, X. & Zheng, S., Jan 8 2021, In: Nucleic acids research. 49, D1, p. D1321-D1327
Research output: Contribution to journal › Article › peer-review

Open Access
Dose-response effect of eribulin in preclinical models of osteosarcoma by the pediatric preclinical testing consortium
Gill, J., Zhang, W., Zhang, Z., Roth, M., Harrison, D. J., Rowshan, S., Erickson, S., Gatto, G., Kurmasheva, R., Houghton, P., Teicher, B., Smith, M. A., Kolb, E. A. & Gorlick, R., Oct 1 2020, In: Pediatric Blood and Cancer. 67, 10, e28606.
Research output: Contribution to journal › Article › peer-review
1 Scopus citations
Evaluation of eribulin combined with irinotecan for treatment of pediatric cancer xenografts
Robles, A. J., Kurmasheva, R. T., Bandyopadhyay, A., Phelps, D. A., Erickson, S. W., Lai, Z., Kurmashev, D., Chen, Y., Smith, M. A. & Houghton, P. J., Jun 15 2020, In: Clinical Cancer Research. 26, 12, p. 3012-3023 12 p.
Research output: Contribution to journal › Article › peer-review
2 Scopus citations

Researchers identify surface protein as a new osteosarcoma therapeutic target for antibody-drug conjugates
Peter J Houghton, Jing Wang & Raushan T Kurmasheva
4/12/21
2 items of Media coverage
Press/Media: Press / Media
University of Texas Health Science Center at San Antonio: CPRIT Awards Mays Cancer Center More Than $10.3 Million
Raushan T Kurmasheva, Luiz O Penalva, Dmitri N Ivanov, Manjeet K Rao, Mingjiang Xu & Ruben Mesa
8/21/20
1 item of Media coverage
Press/Media: Press / Media
Preclinical drug development for childhood cancers
Peter J Houghton & Raushan T Kurmasheva
11/28/19
1 item of Media coverage
Press/Media: Press / Media
Innovative genomics and bioinformatics research at the Greehey Institute
Yidong Chen, Manjeet K Rao, Peter J Houghton, Raushan T Kurmasheva & Yogesh K Gupta
6/18/19
1 item of Media coverage
Press/Media: Press / Media
Epizyme : to Present New Scientific Data on the Role of HMT Inhibitors in Cancer
Raushan T Kurmasheva
11/4/15
2 items of Media coverage
Press/Media: Press / Media